SAFE_DTx: Safety-First Framework for AI-Driven Personalization in Digital Therapeutics

• by Dohyoung Rim

• September 25, 2026

FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A

Fayuvi is authorized for pediatric patients with preserved neurodevelopmental function following a study comparing treated children with a natural history cohort

• September 30, 2026

• 3 min

FDA approves new treatment for FOP

Total new heterotopic ossification volume decreased with treatment and increased with placebo at week 24.

• by Kathryn Wighton

• September 28, 2026

• 2 min

Decomposition of Black and White Infant Mortality Rates

• by Monica J. Alexander, Rohan Alexander, Leslie Root

• September 22, 2026